Nutex Health (NASDAQ:NUTX) Trading Down 4.4% - Here's What Happened

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report)'s share price was down 4.4% during trading on Tuesday . The company traded as low as $160.08 and last traded at $160.63. Approximately 16,904 shares were traded during mid-day trading, a decline of 76% from the average daily volume of 69,988 shares. The stock had previously closed at $167.96.

Analyst Ratings Changes

Several brokerages recently weighed in on NUTX. Maxim Group increased their target price on Nutex Health from $100.00 to $225.00 and gave the company a "buy" rating in a research note on Tuesday, May 20th. Benchmark raised their price objective on shares of Nutex Health from $150.00 to $300.00 and gave the stock a "buy" rating in a report on Thursday, May 15th. Finally, Wall Street Zen cut shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a research note on Thursday, May 22nd.

Nutex Health Price Performance

The company has a quick ratio of 1.74, a current ratio of 1.77 and a debt-to-equity ratio of 3.36. The stock's 50-day moving average price is $130.09 and its 200-day moving average price is $73.29. The company has a market capitalization of $754.86 million, a price-to-earnings ratio of -14.45 and a beta of -0.10.

Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The company reported $2.56 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $2.71. The firm had revenue of $211.79 million for the quarter, compared to the consensus estimate of $81.09 million. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%.

Insiders Place Their Bets

In related news, CFO Jon Christian Bates purchased 1,000 shares of the business's stock in a transaction dated Tuesday, April 8th. The shares were bought at an average price of $81.81 per share, with a total value of $81,810.00. Following the purchase, the chief financial officer now directly owns 4,888 shares in the company, valued at $399,887.28. This trade represents a 25.72% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this link. Company insiders own 38.52% of the company's stock.

Hedge Funds Weigh In On Nutex Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. acquired a new position in Nutex Health during the fourth quarter valued at approximately $672,000. Legato Capital Management LLC increased its stake in Nutex Health by 26.8% during the 4th quarter. Legato Capital Management LLC now owns 31,669 shares of the company's stock worth $1,004,000 after purchasing an additional 6,697 shares in the last quarter. American Century Companies Inc. bought a new stake in shares of Nutex Health during the fourth quarter worth $1,362,000. Truist Financial Corp increased its holdings in Nutex Health by 22.2% during the 4th quarter. Truist Financial Corp now owns 35,570 shares of the company's stock worth $1,127,000 after purchasing an additional 6,454 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in Nutex Health by 12.6% in the 4th quarter. Geode Capital Management LLC now owns 34,125 shares of the company's stock valued at $1,082,000 after buying an additional 3,826 shares during the last quarter. Institutional investors own 5.32% of the company's stock.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.